Sands Capital Ventures as of Sept. 30, 2021
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 13 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Uipath Com Cl A (PATH) | 30.2 | $201M | 3.8M | 52.61 | |
| Doordash Com Cl A (DASH) | 19.6 | $130M | 630k | 205.98 | |
| Dice Therapeutics | 15.6 | $103M | 3.1M | 32.75 | |
| Snowflake Com Cl A (SNOW) | 14.4 | $96M | 317k | 302.43 | |
| Acumen Pharmaceuticals (ABOS) | 7.7 | $51M | 3.4M | 14.86 | |
| Karuna Therapeutics Ord | 4.9 | $33M | 268k | 122.33 | |
| Taysha Gene Therapies (TSHA) | 2.0 | $14M | 725k | 18.62 | |
| 908 Devices (MASS) | 1.6 | $11M | 326k | 32.52 | |
| Candel Therapeutics (CADL) | 1.3 | $8.8M | 812k | 10.84 | |
| Repligen Corporation (RGEN) | 1.0 | $6.5M | 23k | 288.99 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $5.6M | 260k | 21.55 | |
| Spruce Biosciences (SPRB) | 0.7 | $4.7M | 787k | 6.01 | |
| Absci Corp (ABSI) | 0.1 | $672k | 58k | 11.63 |
